University of Cambridge (UCAM)

CONSORTIUM

UCAM is a higher education institution engaged in clinical research that will act jointly with the Cambridge university Hospitals NHS Foundation Trust, a teaching hospital and research center, and other research institutes on the Cambridge Biomedical Campus – together as the Cancer Research UK (CRUK) Cambridge Center.

The CRUK Cambridge Center’s main objective is to conduct impactful interdisciplinary cancer research, deploying Cambridge innovation to better understand the biology and treatment of cancer, including cancers of unmet need. The close proximity of renewed academic, research organizations and laboratories, as well as the presence on site of major industrial partners (AstraZeneca and GSK), encourage and facilitate collaboration across Cambridge between organizations that are dedicated to cancer research.

Role in CCE_DART

Research staff holds expertise on clinical trial design and delivery, statistical methods development, clinical imaging, solid tumor and liquid biopsy molecular profiling and interpretation of clinical relevant results.

The CRUK Cambridge Center is founding member of the Cancer Core Europe (CCE) network and has delivered precision medicine clinical trials in collaboration with CCE members including the molecular stratified Basket of Baskets trial.